ReviewInternational journal of molecular sciences2020

B-Cell Maturation Antigen (BCMA) as a Target for New Drug Development in Relapsed and/or Refractory Multiple Myeloma.

Hanley N AbramsonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.